125 related articles for article (PubMed ID: 21699179)
1. Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Haudecoeur R; Ahmed-Belkacem A; Yi W; Fortuné A; Brillet R; Belle C; Nicolle E; Pallier C; Pawlotsky JM; Boumendjel A
J Med Chem; 2011 Aug; 54(15):5395-402. PubMed ID: 21699179
[TBL] [Abstract][Full Text] [Related]
2. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M
Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816
[TBL] [Abstract][Full Text] [Related]
3. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.
Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M
Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550
[TBL] [Abstract][Full Text] [Related]
4. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
5. Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders.
Eltahla AA; Tay E; Douglas MW; White PA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7215-24. PubMed ID: 25246395
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention.
Ahmed-Belkacem A; Guichou JF; Brillet R; Ahnou N; Hernandez E; Pallier C; Pawlotsky JM
Nucleic Acids Res; 2014 Aug; 42(14):9399-409. PubMed ID: 25053847
[TBL] [Abstract][Full Text] [Related]
7. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.
Nichols DB; Fournet G; Gurukumar KR; Basu A; Lee JC; Sakamoto N; Kozielski F; Musmuca I; Joseph B; Ragno R; Kaushik-Basu N
Eur J Med Chem; 2012 Mar; 49():191-9. PubMed ID: 22280819
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis C viral RNA-dependent RNA polymerase by α-P-boranophosphate nucleotides: exploring a potential strategy for mechanism-based HCV drug design.
Cheek MA; Sharaf ML; Dobrikov MI; Shaw BR
Antiviral Res; 2013 May; 98(2):144-52. PubMed ID: 23466667
[TBL] [Abstract][Full Text] [Related]
10. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
[TBL] [Abstract][Full Text] [Related]
12. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
[TBL] [Abstract][Full Text] [Related]
13. Biochemical study of the comparative inhibition of hepatitis C virus RNA polymerase by VX-222 and filibuvir.
Yi G; Deval J; Fan B; Cai H; Soulard C; Ranjith-Kumar CT; Smith DB; Blatt L; Beigelman L; Kao CC
Antimicrob Agents Chemother; 2012 Feb; 56(2):830-7. PubMed ID: 22143520
[TBL] [Abstract][Full Text] [Related]
14. Preclinical characterization of JTK-853, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
Ando I; Adachi T; Ogura N; Toyonaga Y; Sugimoto K; Abe H; Kamada M; Noguchi T
Antimicrob Agents Chemother; 2012 Aug; 56(8):4250-6. PubMed ID: 22615294
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway.
Sun JM; Kim SJ; Kim GW; Rhee JK; Kim ND; Jung H; Jeun J; Lee SH; Han SH; Shin CS; Oh JW
J Antimicrob Chemother; 2012 Jan; 67(1):49-58. PubMed ID: 22076990
[TBL] [Abstract][Full Text] [Related]
16. In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
Shi ST; Herlihy KJ; Graham JP; Fuhrman SA; Doan C; Parge H; Hickey M; Gao J; Yu X; Chau F; Gonzalez J; Li H; Lewis C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2008 Feb; 52(2):675-83. PubMed ID: 18070954
[TBL] [Abstract][Full Text] [Related]
17. Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV).
Bello-Pérez M; Falcó A; Galiano V; Coll J; Perez L; Encinar JA
Drug Des Devel Ther; 2018; 12():2337-2359. PubMed ID: 30104863
[TBL] [Abstract][Full Text] [Related]
18. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors.
He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742
[TBL] [Abstract][Full Text] [Related]
19. Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.
Okombi S; Rival D; Bonnet S; Mariotte AM; Perrier E; Boumendjel A
J Med Chem; 2006 Jan; 49(1):329-33. PubMed ID: 16392817
[TBL] [Abstract][Full Text] [Related]
20. Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.
Li H; Tatlock J; Linton A; Gonzalez J; Jewell T; Patel L; Ludlum S; Drowns M; Rahavendran SV; Skor H; Hunter R; Shi ST; Herlihy KJ; Parge H; Hickey M; Yu X; Chau F; Nonomiya J; Lewis C
J Med Chem; 2009 Mar; 52(5):1255-8. PubMed ID: 19209845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
